https://www.selleckchem.com/pr....oducts/orforglipron-
40, -0.02], P = 0.04, I2 = 1.8%) and serum aspartate aminotransferase (AST) (WMD -6.97 U/L, 95 % CI = [-12.59, -1.35], P = 0.01, I2 = 64.5%). Also, body weight (WMD -2.70 kg, 95 % CI = [-5.49, 0.09], P = 0.05, I2 = 33.7%) was marginally significant and serum alanine transaminase (ALT) (WMD -6.77 U/L, 95 % CI = [-16.52, 2.97], P = 0.17, I2 = 63.5%) was not statistical significant affected by metformin administration. There was no evidence of publication bias. CONCLUSION In summary, the present study emphasizes the clin
Like
Comment
Share
